Skip to content

Mateusz Skawski

3 papers in the library · 81 citations · publishing 2020-2021

Papers

Sort Most recent Most cited

Tolerance to neurochemical and behavioral effects of the hallucinogen 25I-NBOMe

Psychopharmacology May 25, 2021 Monika Herian, Mateusz Skawski, Adam Wojtas et al. 29 citations

Abstract Rationale 4-Iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25I-NBOMe) is a potent serotonin 5-HT 2A/2C receptor agonist with hallucinogenic activity. There is no data on the 25I-NBOMe effect on brain neurotransmission and animal performance after chronic administration. Objectives We examined the effect of a 7-day treatment with 25I-NBOMe (0.3 mg/kg/day) on neurotransmitters’...

Neurochemical and Behavioral Effects of a New Hallucinogenic Compound 25B-NBOMe in Rats

Neurotoxicity Research December 18, 2020 Adam Wojtas, Monika Herian, Mateusz Skawski et al. 33 citations

Abstract 4-Bromo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25B-NBOMe) is a hallucinogen exhibiting high binding affinity for 5-HT 2A/C serotonin receptors. In the present work, we investigated its effect on dopamine (DA), serotonin (5-HT), acetylcholine (ACh), and glutamate release in the rat frontal cortex, striatum, and nucleus accumbens. Hallucinogenic activity, impact on cognitive...

Contribution of serotonin receptor subtypes to hallucinogenic activity of 25I-NBOMe and to its effect on neurotransmission.

Pharmacological reports : PR December 1, 2020 Monika Herian, Adam Wojtas, Małgorzata Katarzyna Sobocińska et al. 19 citations

4-Iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25I-NBOMe) is a potent serotonin (5-HT) receptor agonist with hallucinogenic properties. The aim of our research was to examine the role of the 5-HT2A, 5-HT2C and 5-HT1A serotonin receptor subtypes in 25I-NBOMe hallucinogenic activity and its effect on dopamine (DA), 5-HT and glutamate release in the rat frontal cortex. Hallucinogenic...